Clinical trial Recruiting at 1 site Observational Ages 18 and up

Fibergraft Aeridyan bone graft for open pilon fractures

Official title: Acute Bone Grafting of Open Pilon Fractures With FIBERGRAFT AERIDYAN Matrix Bioactive Glass

Run by University of Missouri-Columbia · NCT07227493 · Data updated 2026-11-12

This observational study will see if using Fibergraft Aeridyan bone graft matrix helps adults with open pilon fractures heal with fewer infections and nonunions.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment45 (estimated)
SponsorUniversity of Missouri-Columbia
Academic / other
Drugs / interventionsradiation
Locations1 site (Columbia, Missouri)
StatusRecruiting
StartedOctober 24, 2025
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedNovember 12, 2025
Trial IDNCT07227493 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) with an open pilon fracture requiring bone grafting who can provide informed consent and attend follow-up visits are ideal candidates.

Probably not a fit

Patients who do not require bone grafting, who have active infection at the time of definitive care, who receive definitive care elsewhere, or who cannot complete follow-up are unlikely to benefit from this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, observational, single-center study of adults with open pilon (tibial plafond) fractures who require bone grafting. Patients receive standard-of-care surgical management, with the addition of Fibergraft Aeridyan bone graft matrix used to fill metaphyseal bone voids alongside other allografts as indicated. Outcomes will be tracked clinically and radiographically, with two research-only CT scans performed at 6 and 12 months to document healing. The study will monitor infection rates, nonunion, and radiographic incorporation of the graft over the follow-up period.

Why it matters

Potential benefit: If successful, the graft matrix could reduce infection and nonunion rates and improve bone defect filling and healing in open pilon fractures.

How similar studies have gone: Prior work on acute allograft with bone morphogenetic proteins for large defects has shown variable success, and use of this specific Fibergraft Aeridyan matrix has limited published outcome data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years of age or older
* Open pilon fracture requiring bone grafting
* Able to provide informed consent for the study prior to definitive care

Exclusion Criteria:

* Under 18 years of age
* Open pilon fracture not requiring bone grafting
* Receiving definitive care at an outside facility
* Unlikely to make follow-up appointments
* Active infection at the time of definitive care
* Unable to provide informed consent prior to definitive care
* Prisoners
* Pregnant patients

Where it's running

  • University of Missouri - Columbia
    Columbia, Missouri, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.